Vividion Therapeutics' Series A Round

Vividion Therapeutics raised a round of funding on January 18, 2017.

Vividion Therapeutics is a biotechnology company focused on developing therapeutics that treat major unmet clinical needs using a platform for proteome-wide ligand and target discovery.…

Articles about Vividion Therapeutics' Series A Round: